title: Osteoporosis a disease for all; in Lebanon.
abstract: Osteoporosis is the most important metabolic disease leading to fracture and high mortality morbidity rates. With the increase of aging population, mainly in the developing work, it is estimated that the incidence of fracture will rise too. Osteoporosis known in the past to be a woman disease, it is now accepted that it affects man too. The risk factors for osteoporosis are known now, but one vertebral fracture, leading to more vertebral fractures and increasing the risk of hip fracture, stands by itself as an independent risk factor for osteoporosis even if BMD is normal or osteopenic. Vertebral fracture is associated with high mortality rate. At the same time it is work noting that osteoporosis in man is different than in women and finally we have now the means to diagnose correctly the disease, evaluate the fracture risk, treat and monitor the treatment. But incidence, fracture rate, peak bone mass in Lebanon are different than the European or North American one.
authors.affiliation: Saint George Hospital-Balamand University, Beirut, Lebanon.
authors.forename: Maalouf
authors.initials: M
authors.lastname: Ghassan
authors.forename: Nehme
authors.initials: N
authors.lastname: Alexandre
authors.forename: Wehbe
authors.initials: W
authors.lastname: Joseph
authors.forename: Haddad
authors.initials: H
authors.lastname: Fadi
authors.forename: Farah
authors.initials: F
authors.lastname: Georges
authors.forename: Habanbo
authors.initials: H
authors.lastname: Joseph
authors.forename: Gannagé Yared
authors.initials: GY
authors.lastname: Marie Hélène
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D015519:Bone Density; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D006620:Hip Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D007861:Lebanon / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000453:epidemiology* / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D016103:Spinal Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D014807:Vitamin D / Q000627:therapeutic use
chemical_list: D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D014807:Vitamin D; D002118:Calcium